Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 45Colorectal Neoplasms 45Esophageal Neoplasms 28Esophageal Squamous Cell Carcinoma 24Stomach Neoplasms 22Pancreatic Neoplasms 19Colonic Neoplasms 18Adenocarcinoma Of Esophagus 15Carcinoma, Hepatocellular 14Neoplasm Metastasis 7Liver Neoplasms 6Cholangiocarcinoma 5Recurrence 4Locally Advanced Rectal Cancer 4Turcot syndrome 3Peritoneal Neoplasms 2Neoplasms 2Gastrointestinal Stromal Tumors 2Breast Neoplasms 2Bites and Stings 2Adenocarcinoma 2Surgery 1Successful Conversion Rate of Operation 1Radiation Injuries 1QOL; Quality of Life;Gastric Cancer; Gastrectomy;Neoadjuvant Chemotherapy 1Peritoneal Metastases From Gastric Cancer 1Peritoneal Metastases From Colorectal Cancer 1Pathologic Complete Response 1Pancreatic Ductal Adenocarcinoma (PDAC) 1Pancreatic Ductal Adenocarcinoma 1

Interventions

camrelizumab 2spartalizumab 1pembrolizumab 1lenvatinib 1apatinib 1S 1 (combination) 1Neoadjuvant Therapy 1Hyperthermic Intraperitoneal Chemotherapy 1Docetaxel 1Albumin-Bound Paclitaxel 11-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Gastric Adenocarcinoma × Neoadjuvant Therapy × Gastrointestinal × Clear all
NCT02240524 2014-09-15

HIPEC

Affiliated Cancer Hospital & Institute of Guangzhou Medical University

Phase 3 Unknown
582 enrolled
Gastrointestinal

Advanced Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡